Tag: ticagrelor monotherapy

GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men

A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no between-sex difference...

TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI

Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus aspirin, ticagrelor m...